American scientists recently published significant research findings in the journal Nature: the artificial intelligence model FastGlioma, jointly developed by the University of Michigan and the University of California, San Francisco, can quickly assess the presence of cancerous tumor residue within ten seconds during brain tumor surgeries, bringing a revolutionary breakthrough to neurosurgery. This innovation combines microscopic optical imaging with AI foundational models. The research team utilized over 11,000 surgical samples and 4 million microscopic images for pre-training, employing the University of Michigan's self-developed stimulated Raman tissue imaging technology.
